Navigation Links
Researchers uncover why the body can't defend against tuberculosis

Tuberculosis, which kills over 2 million people each year, is caused primarily by infectious bacteria known as Mycobacterium tuberculosis or Mtb. Mtb targets human immune cells as part of its strategy to avoid detection, effectively neutralizing the body's immune response.

Up until now, scientists had a general understanding of the process, but researchers in the Immunity and Infection Research Centre at Vancouver Coastal Health Research Institute and the University of British Columbia have shown Mtb produces a specific protein that allows it to defuse and bypass the body's security system. The results are published today in The Proceedings of the National Academy of Sciences, and provide a pathway for improved treatments against this disease.

"TB has been able to completely mislead our immune systems, convincing our body it isn't there, which is why it is such an effective killer," says Dr. Yossef Av-Gay, research scientist with the Immunity and Infection Research Centre at the Vancouver Coastal Research Institute and professor in the Division of Infectious Disease at UBC Faculty of Medicine. "We discovered that the cells in charge of targeting and destroying invading bacteria are being fooled by a special protein that blocks the immune cells ability to recognize and destroy it."

Here is how it works. Macrophages are dedicated human immune cells with the role of identifying and defeating dangerous microorganisms. Normally, macrophages engulf bacteria, or other infectious agents, and contain them in an enclosed secluded environment. Then, special components of the cell (cellular organelles) move to the controlled area and release acid enzymes that dissolve the bacteria. The system works beautifully against most infectious agents. However, as Dr. Av-Gay's team found, Mtb operates in a stealth manner, turning off this immune response.

In the case of Mtb, once the bacteria become engulfed by macrophages, they secrete a protein named PtpA that disables the two separate mechanisms required for making the acidic environment that normally targets them. The end result is that Mtb lives comfortably in the immune cells, like a Trojan horse, hidden from the rest of the immune system. The bacteria then multiply inside the macrophage, and when released, they attack the body.

"We have been engaged in studying the interaction between the TB bacterium and the human macrophage over the past decade," says Dr. Av-Gay. "We are delighted with this discovery. Through learning about the tricks it uses, we now have new targets, so that we can develop better drugs against this devastating disease."

TB is the leading cause of death among infectious diseases in the world today and is responsible for one in four adult preventable deaths, according to the World Health Organization (WHO). Every 20 seconds TB kills someone, with approximately 4400 people dying every day. The WHO estimates that one-third of the world's population is infected.


Contact: Lisa Carver
604-875-4111 x61777
University of British Columbia

Related biology news :

1. NC State researchers get to root of parasite genome
2. Researchers find animal with ability to survive climate change
3. Researchers find an essential gene for forming ears of corn
4. Researchers note differences between people and animals on calorie restriction
5. Researchers study acoustic communication in deep-sea fish
6. Researchers discover that growing up too fast may mean dying young in honey bees
7. Researchers study how pistachios may improve heart health
8. UI researchers find potentially toxic substance present in Chicago air
9. Researchers develop new self-training gene prediction program for fungi
10. Case Western Reserve University researchers track Chernobyl fallout
11. Childrens National researchers develop novel anti-tumor vaccine
Post Your Comments:
(Date:11/17/2015)... -- Vigilant Solutions announces today that Mr. Dick W. ... --> --> Mr. Boyce ... at TPG Capital, one of the largest global investment ... revenue.  He founded and led TPG,s Operating Group, which ... 1997 to 2013.  In his first role, he served ...
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
(Date:11/11/2015)... Minn. , Nov. 11, 2015   MedNet Solutions ... entire spectrum of clinical research, is pleased to announce that ... in Clinical Trials (PCT) event, to be held November ... be able to view live demonstrations of iMedNet ... and learn how iMedNet has been able to ...
Breaking Biology News(10 mins):
(Date:11/25/2015)... Nov. 25, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... business and prospects remain fundamentally strong and highlights ... doxorubicin) recently received DSMB recommendation to continue the ... review of the final interim efficacy and safety ... Endpoint in men with heavily pretreated castration- and ...
(Date:11/25/2015)... PORTLAND, Oregon , November 25, 2015 /PRNewswire/ ... Deep Market Research Report is a professional and ... Genomics industry.      (Logo: ... basic overview of the industry including definitions, classifications, ... analysis is provided for the international markets including ...
(Date:11/24/2015)... ... , ... The United States Golf Association (USGA) today announced Dr. Bruce Clarke, ... annually since 1961, the USGA Green Section Award recognizes an individual’s distinguished service to ... Clarke, of Iselin, N.J., is an extension specialist of turfgrass pathology in the department ...
(Date:11/24/2015)... /CNW/ - iCo Therapeutics ("iCo" or "the Company") (TSX-V: ... the quarter ended September 30, 2015. Amounts, unless ... presented under International Financial Reporting Standards ("IFRS"). ... Andrew Rae , President & CEO of ... only value enriching for this clinical program, but ...
Breaking Biology Technology: